Home β€Ί Stock analysis β€Ί ACIU

AC Immune SA (ACIU) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

ACIU dips 2.4% to $2.39, a 1-month low. Closed at $2.39, -2.45% vs the prior close of $2.45. Day range $2.38–$2.47, opened at $2.45.

Last close$2.39-2.45%
Day range2.38–2.47
Open2.45
Volume126.85K
52-week range2.10–4.00
Avg volume (20d)217.91K

ACIU daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” ACIU dips 2.4% to $2.39, a 1-month low
Oct 15, 2026 β€” ACIU rises 2.1% to $2.45
Oct 14, 2026 β€” ACIU ends flat (+0.0%) to $2.40, 5 down days in a row
Oct 13, 2026 β€” ACIU dips 2.0% to $2.40, a 1-month low, 4 down days in a row
Oct 12, 2026 β€” ACIU dips 2.0% to $2.45, a 1-month low, 3 down days in a row
Oct 9, 2026 β€” ACIU dips 2.0% to $2.50, a 1-month low
Oct 8, 2026 β€” ACIU dips 0.8% to $2.55
Oct 7, 2026 β€” ACIU rises 2.0% to $2.57
Oct 6, 2026 β€” ACIU slides 7.0% to $2.52, 3 down days in a row
Oct 5, 2026 β€” ACIU dips 0.6% to $2.71
Oct 2, 2026 β€” ACIU slides 3.0% to $2.72

ACIU latest news & SEC filings

Every SEC filing by or about ACIU in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 9, 2026 Β· Form 3/A β€” 3/A filing

3/A filing

Source: SEC EDGAR filing 0000950103-26-015456

Oct 9, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001651625-26-000024

Oct 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001651625-26-000023

Sep 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001651625-26-000020

Sep 3, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0000950103-26-013536

Aug 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001651625-26-000018

Aug 11, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001651625-26-000016

Aug 5, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001104659-26-090704

Jun 30, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0000950103-26-009745

Things to know before you trade ACIU

ACIU market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20262.452.472.382.39126.85K
Oct 15, 20262.432.462.382.4586.90K
Oct 14, 20262.372.412.352.40209.70K
Oct 13, 20262.432.442.392.40194.90K
Oct 12, 20262.502.502.422.45148.50K
Oct 9, 20262.552.592.472.50271.30K
Oct 8, 20262.572.612.502.55231.90K
Oct 7, 20262.522.592.502.57125.10K
Oct 6, 20262.722.722.512.52277.80K
Oct 5, 20262.682.742.652.71221.40K
Oct 2, 20262.842.882.692.72320.20K
Oct 1, 20262.642.842.572.81352.70K
Sep 30, 20262.632.742.612.62199.60K
Sep 29, 20262.652.662.562.60134.20K
Sep 28, 20262.522.622.402.61188.90K
Sep 25, 20262.662.662.452.52323.60K
Sep 24, 20262.852.852.662.66265.30K
Sep 23, 20262.902.912.672.83491.80K
Sep 22, 20262.692.752.662.7378.10K
Sep 21, 20262.632.722.572.65109.40K

About AC Immune SA

AC Immune SA (ACIU) is listed on the Nasdaq and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in 1015 LAUSANNE, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1651625.

ACIU board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Renee Aguiar-LucanderDirectorJun 15, 2026
Monika BuetlerDirectorJun 15, 2026
Carl Howard JuneDirectorJun 15, 2026
Andrea PfeiferChief Executive OfficerMay 18, 2026
Roy Ervin TwymanDirectorJun 15, 2026
Martin ZuegelInterim CEOJun 15, 2026

Executive officers

NameTitleLatest filing
Piergiorgio DonatiChief Operating OfficerMar 20, 2026
Andrea PfeiferChief Executive OfficerMay 18, 2026
Christopher James RobertsChief Financial OfficerMar 18, 2026
Martin ZuegelInterim CEOJun 15, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
May 15, 2026Andrea PfeiferSale10,000$2.79
May 15, 2026Andrea PfeiferSale10,000$2.79
May 15, 2026Andrea PfeiferSale10,000$2.79
May 15, 2026Andrea PfeiferSale10,000$2.79
Apr 15, 2026Andrea PfeiferBuy10,000$3.14
Apr 15, 2026Andrea PfeiferBuy10,000$3.14
Apr 15, 2026Andrea PfeiferBuy10,000$3.14
Apr 15, 2026Andrea PfeiferBuy10,000$3.14
Apr 15, 2026Andrea PfeiferSale10,000$3.14
Apr 15, 2026Andrea PfeiferSale10,000$3.14
Apr 15, 2026Andrea PfeiferSale10,000$3.14
Apr 15, 2026Andrea PfeiferSale10,000$3.14

ACIU financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

ACIU earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on ACIU

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.